PI: principal investigator; UTMDACC: The University of Texas MD Anderson Cancer Center; IGF1R: insulin-like growth factor 1 receptor; mTOR: mammalian target of rapamycin; COG: Children’s Oncology Group; MSKCC: Memorial Sloan Kettering Cancer Center; CTEP: Cancer Therapy Evaluation Program.